1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostaglandin E2 Receptor EP4 Subtype Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 E-7046
1.4.3 ER-886046
1.4.4 grapiprant
1.4.5 KAG-308
1.4.6 ONO-4232
1.4.7 Others
1.5 Market by Application
1.5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2021-2026
1.5.2 Breast Cancer
1.5.3 Allergies
1.5.4 Chronic Pain
1.5.5 Acute Pain
1.5.6 Lung Cancer
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Perspective (2021-2026)
2.2 Prostaglandin E2 Receptor EP4 Subtype Growth Trends by Regions
2.2.1 Prostaglandin E2 Receptor EP4 Subtype Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Regions (2015-2020)
2.2.3 Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Regions (2021-2026)
3 Market Competition by Manufacturers
3.1 Global Prostaglandin E2 Receptor EP4 Subtype Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Prostaglandin E2 Receptor EP4 Subtype Average Price by Manufacturers (2015-2020)
4 Prostaglandin E2 Receptor EP4 Subtype Production by Regions
4.1 North America
4.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.1.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in North America (2015-2020)
4.1.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.1.4 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.2.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in East Asia (2015-2020)
4.2.3 East Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.2.4 East Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.3.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Europe (2015-2020)
4.3.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.3.4 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.4.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in South Asia (2015-2020)
4.4.3 South Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.4.4 South Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.5.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.5.4 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.6.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Middle East (2015-2020)
4.6.3 Middle East Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.6.4 Middle East Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.7.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Africa (2015-2020)
4.7.3 Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.7.4 Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.8.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Oceania (2015-2020)
4.8.3 Oceania Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.8.4 Oceania Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.9.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in South America (2015-2020)
4.9.3 South America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.9.4 South America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2026)
4.10.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
4.10.4 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
5 Prostaglandin E2 Receptor EP4 Subtype Consumption by Region
5.1 North America
5.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.10.2 Kazakhstan
6 Prostaglandin E2 Receptor EP4 Subtype Sales Market by Type (2015-2026)
6.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Type (2015-2020)
6.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Type (2021-2026)
7 Prostaglandin E2 Receptor EP4 Subtype Consumption Market by Application(2015-2026)
7.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Application (2015-2020)
7.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Application (2021-2026)
8 Company Profiles and Key Figures in Prostaglandin E2 Receptor EP4 Subtype Business
8.1 Eisai Co Ltd
8.1.1 Eisai Co Ltd Company Profile
8.1.2 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification
8.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Ono Pharmaceutical Co Ltd
8.2.1 Ono Pharmaceutical Co Ltd Company Profile
8.2.2 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification
8.2.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Eli Lilly and Co
8.3.1 Eli Lilly and Co Company Profile
8.3.2 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Specification
8.3.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Kaken Pharmaceutical Co Ltd
8.4.1 Kaken Pharmaceutical Co Ltd Company Profile
8.4.2 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification
8.4.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Rottapharm Biotech Srl
8.5.1 Rottapharm Biotech Srl Company Profile
8.5.2 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Specification
8.5.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 RaQualia Pharma Inc
8.6.1 RaQualia Pharma Inc Company Profile
8.6.2 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Specification
8.6.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Prostaglandin E2 Receptor EP4 Subtype (2021-2026)
9.2 Global Forecasted Revenue of Prostaglandin E2 Receptor EP4 Subtype (2021-2026)
9.3 Global Forecasted Price of Prostaglandin E2 Receptor EP4 Subtype (2015-2026)
9.4 Global Forecasted Production of Prostaglandin E2 Receptor EP4 Subtype by Region (2021-2026)
9.4.1 North America Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.3 Europe Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.7 Africa Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.9 South America Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Application (2021-2026)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.2 East Asia Market Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.3 Europe Market Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Countriy
10.4 South Asia Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.5 Southeast Asia Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.6 Middle East Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.7 Africa Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.8 Oceania Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.9 South America Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
10.10 Rest of the world Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.2 Prostaglandin E2 Receptor EP4 Subtype Distributors List
11.3 Prostaglandin E2 Receptor EP4 Subtype Customers
12 Industry Trends and Growth Strategy
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis
12.5 Prostaglandin E2 Receptor EP4 Subtype Market Growth Strategy
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer